text:
Special report: How Cowboys, victim's mother still support Josh Brent one year after Jerry Brown's death
If forgiveness is indeed the gift we give ourselves, Stacey Jackson has enough to share with everyone.
From the moment she learned her first-born son had died in a car wreck, Jackson offered her forgiveness to the man who was responsible for her heartache.
One year later, that hasn't changed.
Sunday will be yet another difficult day for Jackson. It's been a year since her son, Jerry Brown Jr., a practice squad linebacker for the Cowboys, died while riding in the passenger seat of a car driven by Cowboys defensive tackle Josh Brent, who, according to accident reports, was intoxicated.
On the anniversary of her son's death, Jackson will be at work but plans to call Brent — as she has every week since that tragic night in Irving — and console him. Someone is also making a Cowboys cake for her, and she plans to pass out pieces to her co-workers.
The accident created a ripple effect across the Cowboys organization, affecting the lives of the wealthy and famous who — ultimately — are no more bulletproof than the common man.
Cowboys safeties Barry Church and Danny McCray still reflect back on that day that started with video games but ended with regrets about what they could have done differently.
Cowboys coach Jason Garrett and owner Jerry Jones have drawn closer to Jackson and have gone to great lengths to stay in contact with her and Brent. The Cowboys recently even helped Brent find a job.
A remarkable woman
During the tougher times over the last year — Mother's Day, her son's birthday in October, Thanksgiving — Jackson has leaned on her strong faith and baby granddaughter to help get her to the next day.
Seven weeks after Brown died, his first child was born: Mya Lee Brown. The NFL has extended benefits to Brown's daughter. The baby's mother, Andrea Bosquez, lives in San Antonio, and Jackson stays in constant contact with the two. They just spent Thanksgiving with Jackson at her home in Champaign, Ill.
"This right here is unbearable," Jackson said. "If I didn't have God on my side, I don't know where I would be."
Jackson said she would be a hypocrite if she didn't forgive Brent because she emphasized forgiveness when raising Brown and her younger son, Jeremiah.
"If being mad at Josh would bring Jerry back, I would be the No. 1 person. I would be mad as hell at him," Jackson said. "It takes too much time and too much energy to be mad and frustrated at him when who is me? I'm a nobody."
Jackson is far from nobody. She's a remarkable woman who has developed a relationship with Garrett and Jones through the death of her son.
Garrett has called Jackson every month since her son died to see how she's doing. Jones has phoned Jackson every other month.
"They don't have to do that," Jackson said. "My son is gone. He was on the practice squad. He was really a nobody. For them to call and do that is special. The Dallas Cowboys are in a class by themselves."
Garrett even called Jackson on Mother's Day and Brown's birthday in mid-October.
"She's a really special lady, and it's been great for me to get to know her, not under the circumstances that we wanted to, but I told her Jerry is a part of our family and she's a part of our family, and if there is anything we can do just to reach out and let us know," Garrett said.
"The way she handled it was remarkable to me and inspired me and so many other people, the love, the care, the forgiveness she expressed to Josh Brent and just her ability to process it all in the way that she has is really inspirational."
Jones said Jackson has been "unbelievable."
"It gives us all a model of how to deal with tragedy," Jones said. "A year later, this thing hasn't gotten one bit easier for her or any parts of her family, but she has that beautiful little girl. I know everybody else involved is still just looking at the tragedy and the lives that were impacted by this."
That fateful night
The Cowboys are scheduled to board a plane at 2 p.m. Sunday to fly to Chicago for their Monday night game against the Bears. A year ago, the players had just boarded the team plane when they were told about the accident before flying to Cincinnati.
At least eight Cowboys players met at a northwest Dallas club on the night of Dec. 7, 2012 and partied into the early-morning hours.
A year after Brown's death, some players who were among the last to see him alive finally opened up this week about that fateful night.
McCray said about five teammates met up at his home to play video games for a few hours before they separated to go eat. They met back up late that night at Beamer's Nightclub for drinks.
Some time at about 2 a.m., the players left the club and went their separate ways. Church said he had a driver that night and so did McCray, but the other players didn't.
Church and McCray said they have struggled at times over the last year with their grief, and both said they have regrets about that night. Both, however, said they believed Brent was OK to drive when he and Brown left the club in Brent's four-door Mercedes S600.
"It was a night that everybody has. Everybody had maybe a little too much to drink," Church said. "Nobody thought maybe we should get [Brent] a ride. He seemed intoxicated, but not like, 'Ah, I can't make it type.' We've all been there. We've all been behind the wheel a little intoxicated."
McCray said he and Church had hung out a lot with Brent and didn't see him acting any differently when he left the club that night.
"We all could have done things differently, but us being as good of friends as we are, we had seen each other enough to kind of be able to gauge it," McCray said. "We didn't think there was an issue. He looked fine. Apparently, the situation happened a little differently."
Brent was speeding when his car flipped and caught fire as he headed west on the service road of State Highway 114 near Loop 12, according to accident reports. His blood-alcohol level was found to be more than twice the legal limit after officers drew Brent's blood the morning of the crash.
Brent's Mercedes hit a curb, overturned and slid on the roof for more than 870 feet before it came to rest. Neither Brown nor Brent was wearing a seat belt.
Church said he thought Brent would be OK because he lived so close to the nightclub.
"Everybody has done it before. I was like, 'His house is right down the street, and he'll be fine,'" Church said. "Then we got a call saying what happened, and it was devastating."
Devastating news
The Cowboys' team flight to Cincinnati was quiet. The players and coaches filed into the team hotel with blank expressions across their faces, not saying a word to fans who awaited their arrival.
The next day, the Cowboys were numb, grieving and distracted.
"We were getting taped before the game, and everybody has tears in their eyes," McCray said, "wondering what we're going to do."
What they did was find a way to rally for an emotional 20-19 victory. Tears poured down the faces of some of the players after Dan Bailey made the winning field goal as time expired.
After it was over, Garrett called Jackson on the phone and presented her with a game ball.
"It was as difficult a game as I've ever been around because of the emotions and circumstances," Garrett said.
The Cowboys flew back to Dallas and two days later attended a private memorial service for Brown in Oak Cliff. Jackson asked for Brent to meet her at the airport and sit with the Brown family during the service. The following Saturday, Brown was buried in his hometown of St. Louis.
Jackson's other son, Jeremiah, was so devastated he couldn't attend the funeral. Jackson said she videotaped the funeral for her son, but he took weeks before he was able to watch it.
Offering support
Brown and Brent were best friends, lived together and played college football together at Illinois.
Those who talk to Brent weekly say he continues to have a hard time with Brown's death but now has a job outside of football as he awaits his trial. Brent has been charged with intoxication manslaughter, and a Dallas grand jury added a second manslaughter count against him two months ago in connection to the crash. Brent, who served 30 days in an Illinois jail for driving drunk in 2009, faces up to 20 years in prison if convicted.
"It's obviously been a very difficult and agonizing year, and our hearts and prayers still go out to Jerry Brown's family," said Brent's attorney George Milner.
Milner said the trial date is set for Jan. 8.
The Cowboys still support Brent who retired from football before the season. Earlier this week, Church was at Brent's house, and Brent visited McCray's house to play video games.
Jones said he talked to Brent three weeks ago. Jones said Brent has a daughter to support, and the Cowboys helped get Brent a job at a local warehouse driving a forklift.
"I wouldn't say he's doing better," Jones said. "He still grieves and has the remorse of the accident. He knows his life will never be the same. He understands he has a lot ahead of him."
Jackson said she's worried about Brent taking his own life, so she often checks in with him.
"It's those lonely times when you're by yourself and when you're uneasy and you start wondering in your mind, and it makes you do stupid things," Jackson said.
"I can never get this sight out of my mind with my son laying on the table at the funeral home, and if I can't get that out of my mind, I'm sure he can't get it out of his mind with the accident."
Jackson said, however, she's never asked Brent about details from the night of the accident.
"Because you know what, it's not going to bring my son back," Jackson said. "I don't want to know details about that. He lives it over and over again every time, and I don't want to live it over with him."
But Jackson grieves with Brent. She said she's thankful for the NFL's support for her granddaughter. Jones said the NFL extended financial and educational benefits to Brown's daughter.
"Jerry left his daughter in inordinate financial shape if you consider the raising of a child and the education of a child in that respect," Jones said. "I'm proud for their family that she'll have that kind of life. That's in place."
Jackson and Brown's father, Jerry Brown Sr., recently filed separate civil lawsuits against Beamers Nightclub, alleging the club served alcohol excessively to Brent.
Jackson has started a scholarship program in her son's name that will award four scholarships next year to students.
Jackson said she's returned to St. Louis four times to visit her son's gravesite. The last time was on Brown's birthday in October, when she had a headstone added.
"When I go and visit, I still can't believe this and I can't believe that my son is here," Jackson said, her voice cracking as she cries. "Sometimes it's hard even though I know wherever I'm at, he's at. To go there and see his headstone, it's really hard.
"I didn't think I was that strong, but I've learned through all of this I am very strong and that everything happens for a reason, even though we don't understand what that reason is for, and the main thing I've learned is tomorrow is not promised to us."
Follow Brandon George on Twitter at @DMN_George
Get the latest Dallas sports news at SportsDayDFW.com


text:
95 honda civic
my 95 honda civic 1.5 L dohc ran out of gas. I refilled it , it ran for a few mins then died now will not restart. Theres fuel pressure at both ends of the fuel filter, theres presure at the fuel rail, the pump sounds like its priming. there incoming spark to atleast 2 of the plugs(havent tested the other 2 yet). I was told it could be either airlocked and i should try priming it with starter fluid, also could be the main relay which don't make sence. would love some advice thank you.
Tutor Answer
Brown University
1271 Tutors
California Institute of Technology
2131 Tutors
Carnegie Mellon University
982 Tutors
Columbia University
1256 Tutors
Dartmouth University
2113 Tutors
Emory University
2279 Tutors
Harvard University
599 Tutors
Massachusetts Institute of Technology
2319 Tutors
New York University
1645 Tutors
Notre Dam University
1911 Tutors
Oklahoma University
2122 Tutors
Pennsylvania State University
932 Tutors
Princeton University
1211 Tutors
Stanford University
983 Tutors
University of California
1282 Tutors
Oxford University
123 Tutors
Yale University
2325 Tutors

subset: commoncrawl


text:
Vendor Response: We regret that this didn't work for you. We wish we could have given you a couple of tips before having to throw the product away. If there is a next time that you get this slip; the lace is applied by chain stitch, so that you can turn the garment inside out, then pull the thread and all the lace comes off. There are two threads at the seam. One will pull more easily than the other, so pull the one that takes the lace off with a gently tug. The lace layer comes off easily.
Diana from W


text:
Last week I wrote about loops and how some students seem to have trouble with them. On the link to it from Facebook one friend of mine asked "what's a for loop?" He's a Scheme sort of guy and a lot of looping in functional languages like Scheme is done with recursion. So I thought I should play with recursive loops a bit. Just for the fun of it. Yeah, some of us do play with code for fun. Recursion in general gives some students trouble. I must confess that I struggled with it for a while. For me I found the idea of using recursion for looping to be unnecessarily complicated. That is probably a function of not using a functional language though. This is probably a good part of the argument for students learning several programming paradigms BTW.
Students of mine have several times discovered recursion on their own. Often this is because they are learning a new programming language so they know that loops exist but they do not know the syntax in the new language. So they think "well I can have the function call itself." Often they decide to have main (or equivalent) call itself. Generally not a great idea. The worst part is that they don't think about all the parts of a loop – specifically they forget about the check to see if the loop is finished. This is when we have a teachable moment to talk about stack overflows." So generally it is best to have a separate routine that calls itself after being called initially from outside. For example:
Module Module1
Sub Main()
GoDeep(0) ' Set initial condition in first call
End Sub
Sub GoDeep(ByVal i As Integer)
Console.WriteLine("Up " & i.ToString)
If i < 9 Then ' Are we done yet?
GoDeep(i + 1) ' if not, change the condition and call ourselves again
End If
Console.WriteLine("Down " & i.ToString)
End Sub
End Module
This program prints out the following:
It's still a loop of sorts and it follows all the same rules for for loops, while loops, do loops and all the other sorts of loops in procedural languages.
Of course if you use recursion too deeply you get something like this:
This demonstrates one other problem with recursion though – it takes a lot of resources. So while there are times when nothing but recursion will do I generally prefer "regular" loops when those will do the trick.


text:
Summary (For those who don't want to wade through the long version that I will post):
After debating about which language school to attend in Italy, I settled on Lucca Italian School (LIS) http://www.luccaitalianschool.com/. I chose Lucca because I had never been there and the good train connections to nearby towns made the location even more appealing (more about that later). I had an incredible experience and hope I can convey what attending the school was like in this TR.
I have about 8 years of Italian under my belt. I have studied with community ed, attended courses at the university and met with a small group and tutor. I have got the grammar down but Italian just won't come out of my mouth. After two weeks at LIS, I still cannot speak Italian fluidly. However, some things I knew became clearer and I learned some new strategies for studying Italian back home (e.g., I picked up "Dizionario Italiano per Stranieri" an Italian dictionary with explanation of Italian words in Italian). And I did recharge my batteries in regards to studying Italian. Mainly, though, I had an excellent time enjoying Lucca and meeting new people.
My fellow students were a mix of ages, although most were probably over 40. There was a nice mix of nationalities. The classes I was in had between 6 and 8 students. There were fun activities available in the late afternoon, if you wished to join (some for a fee).
The teachers spoke only Italian to us, even during the optional activities. Some students tried to speak Italian out of class while others needed the break from Italian. (I wish I had followed one student's example in seeking out a non-English speaking student to have lunch with, thereby forcing the conversation to be in Italian.)
The teachers employed a mix of education strategies and were well prepared: worksheets, conversation partners, songs, games. One bit I thought was fun and helpful was having one conversation partner witness a crime and then describe the crime scene to the other partner, the investigator. A game based on the "Taboo" board game was also very instructive and fun. The hours in class flew by!
I am glad I chose Lucca, although I never really did take advantage of the great train connections! I was so engaged by Lucca that I was happy to stay there and explore. The cathedral has some fine art (including the exquisite funeral sculpture of Ilaria del Carretto by Jacobo della Quercia). The church of San Frediano was interesting, with a fine mosaic outside, and inside, a Della Robbia, a Romanesque baptismal font and the mummified body of the local saint, Zita. Also interesting was the Chiesa dei Santi Giovanni e Reparata, where you can explore the archeological digs underneath the church and see Roman and medieval era remnants. There are a number of Puccini concerts available, for those who enjoy opera. Of course, there are the walls, which are a pleasure to stroll around, enjoying the views and the bicyclists, joggers and walkers passing by. We were there for the on-going celebrations of the 500th anniversary of the walls and got to see antique vespas, Fiats and Ferraris drive through town.
I also thought Lucca was a good choice for the opportunity to practice Italian. The main streets, San Paolino and Via Fillungo, seem to attract the most tourists. But step away from those areas and there are many small stores where the shopkeepers are willing to patiently hear your request in Italian and answer in kind. I enjoyed trying my Italian out in the many small shops where I bought cheeses, wine, and other groceries to stock my Lucca apartment. After only two weeks, it began to feel like home.
Recent Activity
- Announcement:
- TEST (do not reply)
by ibobi | Posted on Nov 20, 17 at 01:24 PM
- 1 Iceland driving in March
- 2 Malaga Christmas lights
- 3 Sampling Some of Sicily and Bits of Italy Beyond
- 4 Where to Eat in Barcelona
- 5 Festival du Citron (Lemon Festival), Menton
- 6 Is Bologna ok for a 3 months stsy?
- 7 Advance tickets for Sagrada and Park Guell
- 8 10 days in Cologne Munich Switzerland
- 9 And the winner is ...India? Egypt? no, Italy!
- 10 First - but not last - trip to Greece
- 11 Must See/Do/Eat in Vienna?
- 12 My France Vacation
- 13 Is it hard to find a job in Nikolaev, Ukraine?
- 14 Tour Company recommendations for St. Petersburg
- 15 London vacation rental agency
- 16 Greece during Easter week or August
- 17 Northern Spain road trip
- 18 Manchester Christmas Markets 2017
- 19 Help with Spain itinerary
- 20 More time in Belgium or Germany?
- 21 Paris, Normandy & Amsterdam with College Graduate
- 22 Buying RER Ticket CDG-Paris
- 23 Where to stay in Naples?
- 24 Driving
- 25 Itinerary for 4 days in Madrid
Learning the Lingua: in Lucca: 2 wks at Lucca Italian School (May 2014)
Summary (For those who don't want to wade through the long version that I will post):
Report Abuse
Brava, mama_mia. Having done 3 separate weeks at 3 different language schools in Italy, the one thing I wish I'd been able to do is to spend longer there! I'm sure that 2 consecutive weeks is 3x better than 2 separate weeks - do you agree?
looking forward to reading more about your experiences.
Report Abuse
I found after 2 weeks I was getting into the rhythm of thinking in Italian while walking around town. Even when I sent texts or emails to my husband, I was constructing them in my head in Italian first, and until I realized it was not necessary!
So 2 consecutive weeks was good and of course more would be better.
Report Abuse
I meant to add in my summary that a few of the students I met were youngish (50's?) widows. I thought a language school would be a good way for someone used to traveling with a spouse to dip his/her toe into solo travel. You have a group of people available to socialize with--or not.
Also meant to add my thoughts about how well the school was run. I received prompt and patient replies to my inquiries, even when I was changing my mind about dates and accommodations. The administrators and teachers go out of their way to make LIS a welcoming place--even tracking down an Italian whom one of the students had known but lost contact with. Just lovely people.
Report Abuse
it sounds like a very good school, mama_mia. I too have been impressed with the schools I have attended and I will certainly add this one in Lucca to my list of possibles for the future.
Report Abuse
Thanks for this report. I recently completed a week of classes in Rome, and hope to do a week (or two) at a different school/location next year. I'll certainly check out this one -- sounds like it was a great experience!
Report Abuse
Thank you so much for telling about your experience. I'm so wanting to do a week or two at a language school in Italy.
Report Abuse
If a person had basically no language skills in Italian, would they have been in over their head, or did they have absolutely beginner classes?
Report Abuse
if you excuse my butting in, Sassafrass, most italian language schools have beginner classes, but unlike classes for those with some italian, they usually require beginners to do at least 2 weeks and to start on a specific day.
the latter is required by the school in lucca - see their dates and prices page:
IME schools are very good at grading their pupils and trying to match them to the right level as that way you make most progress, and hopefully, come back and/or tell your friends!
Kay - if you get the chance to go to a school, do it - but do try to attend for 2 weeks. I have found that after a week I am just getting into it and then i've had to go home.
Report Abuse
As Annhig noted, the beginners start on a specific Monday. I got the impression from talking with the beginning students that they had not taken formal classes previously. At most, they may have listened to CDs, if that. So, don't hesitate to jump in.
Report Abuse
Here's a day by day description of my weeks in Lucca--hopefully informative for those curious about how the school week went and hopefully not too boring.
After arriving in Rome (FF miles), I spent two nights in Pistoia. I enjoyed walking around this lovely town, despite the overcast and rainy weather. On Sunday, I headed to Lucca and to the apartment for my home stay. The home stay was arranged by the school and when I pulled up in my cab, shouts of "ciao, Denise" came from the balcony as my host, M, and another student greeted me. I elected to do the home stay the first week to get more opportunities to speak in Italian. (M only spoke to me in Italian, but I suspect she could speak, or at least understand English. I was grateful that she was patient with me!) I chose to do "room with kitchen privileges" because I did not want to feel locked into dinners at certain times. But M kindly prepared a wonderful soup for us that first day and J shared her dinner with me.
I had my own room but shared a bath with the other student, J, who kindly showed me the way to the school (5 min walk) and then showed me a bit of Lucca that afternoon. J has returned to LIS several times, sometimes for as long as 3 months. I am jealous of her progress in Italian, but when I hear how she works at it, it is understandable. Back in the U.S., she attends classes, listens to and reads Italian online and skypes, among other things.
When I arrived at the school, I took a brief test and was assigned to my group, an advanced class. There were 7 of us the first week: 3 U.S., 2 English, 1 Australian and 1 Swiss. Our teacher, Susanna, spoke only Italian to us. We began class at 9:15, took a 15 minute break at 11:00 (where everyone headed to one of two bar/patisseries steps away) and then resumed classes until 1:00. Although I have a solid background in grammar, my speaking abilities are poor. A few of the students who have spent time previously in Italy were more fluid speakers. I never felt awkward in class, though; the teachers and other students create a very welcoming environment. Everyone was there because they love Italian; being in Italy practicing Italian made us happy!
The school offers optional afternoon activities. Some have a small (and I always thought reasonable) fee; others have no charge. The first day, I participated in a walking tour of Lucca. The teacher who led the tour gave some history of the city, but she also pointed out places where we might want to go for wine, groceries, bread, etc.
Both the school and the apartment were outside the walls of Lucca but an easy 10-15 minute walk into the historic centro. That evening I went for a walk on walls, which encircle the city and are over 4 kilometers long. The wide path (wide enough for cars) is flanked by trees; at various points, the bastions jut out. While walking, I bumped into another student, JT, who was jogging on the walls (you will see walkers, joggers, bicyclists, surreys, dogs). We agreed to meet for dinner. The rest of my time in Lucca would go like that—chance encounters with other students and then a plan to meet for an appertivo or dinner.
The next day (Tuesday, wk 1), we worked on conjunctions like tuttavia, nonostante, pero. We usually did a combination of learning activities in class: worksheets, conversations with another student, preparing a paragraph or two, playing a game. I was anxious to learn these conjunctions since they seem to make sentences flow better. My favorite word is "allora," which seems to be a catchall transition expression. In the afternoon, there was a movie in Italian.
At different times through the year, LIS offers additional packages that combine morning Italian lessons with afternoon activities built around cooking or walking. The first week I was there, the walking program was available, but I chose not to participate because I wanted afternoons free for trips (yes, trips that I did not take anyway). However, one of the students in the walking program opted out of a Cinque Terre hike and I took her place.
Angelo, one of the directors of the school, picked us (6 students) up early that morning for the drive to La Spezia. From there, we took a train to Levanto, where we would begin our hike. It was a steep uphill climb but rewarding as we skirted the coast. Finally, Monterosso al Mare came into view and we began the equally steep descent into town. We had a nice lunch at La Barcaccia and then brief visits to the old town and, later, Vernazza. Both places were crazy crowded with tour groups and student groups. Then back to relatively peaceful Lucca.
Thursday's optional activity was "Myths and Legends of Lucca"—a walking tour followed by an apertivo. The charge for this was 10 euros, I believe. Antonella, the teacher who led this tour, spoke slowly enough so that even the newer students followed her stories. Later, I met a group of students and teachers for dinner at Mecanate. Wine, good food and chatter flowed freely.
I was sad to see the first week end. Although I was learning a lot, I felt the need to drop down a class and cement some of the things I already knew, before venturing into new territory. There was no problem with adjusting my placement. I am not sure this would always be the case as the classes grow more crowded in the summer; but then there may be more classes and more levels to begin with.
Some students had activities planned for the weekend, but I had plans to move into an apartment and do laundry! I was able to check into my lovely apartment in the centro early (http://www.myflatinlucca.com/en), so I wandered by the market that is held every Saturday along the walls. There were the usual stalls of clothing and household items, but only a few fruit and vegetable vendors. I managed to get some delicious apricots and strawberries though and use some Italian.
Sunday, I strolled around town, checking out some used book stalls, and then bumped into a student, D; while we were talking, a parade made up of young people from the contradas went by, so we watched them for a bit. That evening, I met my old roommate J for a performance of "Tosca."
Report Abuse
That all sounds like a lovely dream. We spent a few days in Lucca once and loved it. It would be a great place for language school. I've thought about it before, but you really did it, gives me something to think more about. Thank you for sharing your experience.
Report Abuse
Thanks, Sassafrass. I think it is a great way to get a more in-depth experience--it forces you to slow down.
Here's the rest of my report, including what for me was a highlight--a cooking lesson and dinner:
Monday (wk 2) Back to school and a new group: 1 Canadian, 2 U.S., 1 German, 1 Brazilian, 1 Swiss. Our teacher, Eva, kept us busy with some games and exercises. In the afternoon, I again strolled through town, checking out things I had missed on previous strolls. I tried to study every day, and that day I decided to stop in the Anfiteatro for a Spritz (Aperol based apertivo). The Anfiteatro is an oval shaped piazza, lined by shops and restaurants/bars and on the site of a Roman amphitheater that once stood outside the Roman era walls. However, I did not get much work done because of the apertivo and the people watching.
Tuesday (wk 2) may have been the highlight of the school week for me. The optional activity was a dinner prepared by the students under the direction of Eva, my teacher, with the assistance of Antonella, another instructor. We worked in one of the classrooms that had a rudimentary kitchen attached (2 burner stove, sink and toaster oven, I think). Eva managed to herd 10 students of various nationalities and abilities through a meal of bruschetta, pasta with zucchini, leeks and saffron, rolled turkey breast stuffed with pancetta and frittata and simmered in a wine sauce with olives, and a dessert made with mascarpone, amaretto and chocolate. We all had a hand in the chopping of the vegetables and also in making the pasta dough and either running it through the machine or cutting by hand. The food was unbelievably delicious. I consider myself a good cook, but I cannot imagine directing 10 wine-infused students in Italian under those conditions!
Wednesday (wk 2) and I finally took one of those trips I had planned when I chose Lucca. I had been so busy enjoying the company of fellow students, participating in field trips, or just exploring Lucca that I did not feel the need to leave Lucca. But I forced myself to travel to Montecatini and was joined by a fellow student, P. Montecatini Terme was a refreshing change of pace, architecturally. It is a spa town ("Terme" for the spring-fed baths) and one of its hey days was in the late 19th/early 20th centuries. There is a good bit of art nouveau/Liberty style architecture. We also explored Montecatini Alto, the old town that is reached by a funicular.
After class Thursday, I had a private lesson with Antonella. This gave me a bit more confidence in speaking Italian. When I expressed frustration with my inability to speak, Antonella reminded me that it is normal and expected. We talked about strategies I might use back home. I met up with a few students for an appertivo at our usual place and a last dinner together.
Friday (wk 2). I was truly sad to see the end of this journey. The teachers at LIS were wonderful and I really enjoyed getting to know the other students. My goodbyes were quick, though, because my husband was arriving at the train station to join me on the next part of my trip. Hopefully, this was truly only "arriverderci."
I finished out my time in Lucca with my husband, showing him my favorite sites, enjoying an appertivo at my usual place (the waitress knew to bring me a prosecco), and checking out two wonderful restaurants (Osteria Del Manzo and Canuleia, with its romantic courtyard dining). It was a busy weekend in Lucca, with many antique vespas, Fiats and Ferraris on hand for the celebration commemorating 500 years of the walls. (The museum next to the Guinigi tower has a good exhibit explaining the series of walls that were built, moving out as the city expanded through Roman times to the Medieval era and late Renaissance.)
Then on to Cinque Terre and Rome.
Report Abuse
What a great time you had, mama. people sometimes look at me sideways when I say that I'm spending my holiday effectively at school but what they don't realise is how much fun it is!
Report Abuse
What a wonderful experience! I've often had the thought of attending language school in Italy drift through my mind and reading this report seems like bliss to me!
Report Abuse
The only thing that would top my previous visit to Lucca might be staying in Lucca and going to this school! Thanks for the tips!
Report Abuse
I am starting at LIS on Monday 16th June as a raw beginner and am feeling very nervous indeed.
The full immersion sounds daunting and am worried i will have bitten off more than i can chew, so to speak.
Ay words of encouragement at this point would be most welcome!
Report Abuse
Brava, mama_mia! Add this to my growing Italy bucket list....sigh.
Report Abuse
Thanks for the kind responses.
Susierieg, I am soooo jealous. I wish I was back at the beginning of my adventure.
I am sure you will have an enjoyable experience. There are no tests to stress over and you are not being graded on your Italian.
I am not sure what you mean by "full immersion." I was only in class until 1:00 each day, but I joined in some of the late afternoon activities, which generally were only an hour or two. The mornings flew by and I almost wish I had more time! Are you taking additional private lessons?
Whatever your plans, I would not stress about it. As an adult learner (I earned an M.A. in my 50s), I personally find it somewhat harder to retain things. But I appreciate and enjoy the learning process so much more than when I was a younger student.
You will find (and I am sure this is true of all the good language schools), that the teachers work to create a welcoming and supportive environment. They know the challenges that they face (short courses, students starting and stopping at different times, students with various levels of proficiency, different goals and different native languages, etc.).
As a student, it is helpful to keep these challenges in mind regarding your own expectations for what you can achieve in the course. I felt that my 2 weeks served as an injection of Italian, boosting my knowledge. I did not expect to speak fluently and probably never will, without an extended stay in Italy and a younger brain. But a longer period of study combined with more time practicing Italian and hearing the language will probably move me further along in my goals. Good enough.
Have fun!
Report Abuse
good luck, susie. i'm sure that you'll have a wonderful time, making lots of new friends and having a few adventures.
as a beginner there are no goals except those you set yourself and we are all different - language learning is not a competition! so don't get discouraged if you seem to be getting on more slowly than others, or have other problems, none of that matters. you may find that you get it straight away, or that it takes time before the penny drops. And nothing you do is a waste of time, even if you are struggling - believe you me we ALL struggle, and as mama_mia says, it gets harder the older we get.
Finally there is nothing wrong in saying you don't understand - quite often other people haven't understood either but were too scared to say so - you will be doing them a favour!
Report Abuse
Thank you Mamma_Mia and Annhig!
That is most helpful.
I am in my 50's and have not studied for a very long time.
By full immersion i just meant the teachers don't speak English at all during class. I think that is scaring me the most.
Any way I am very much looking forward to it!
Report Abuse
Even in beginner classes I have taken in the U.S., the teachers have tried to speak and explain only in Italian. In the courses in Italy, it is also necessary because not all of the students speak English. Somehow, they get the message across.
But, again, don't worry. Among the first phrases you will learn will be "I don't understand" (Non capisco), "How do you say?" (Come si dice?), and "How do you write?" (Come si scrive?)
Report Abuse
Mama mia,
Complimenti, tu sei molto brava!! Thank you so much for this wonderful report! Lucca is one of my favorite cities in Italy. As a matter of fact, my first time there I attended Koine language school , where Angelo from LIS was the manager. i'm very happy to hear that LIS is such a good school as Ive been wanting to return to Lucca for Italian classes but didnt like Koine. So now I know ive found a good school option there.
Report Abuse
Nice report and now I wish we had stopped in Lucca. Another trip.
Report Abuse
Cruiseluv - I think you would be happy with the situation at LIS, so if you are hankering to return to Lucca, it would be a good choice.
flpab - so many places, so little time - right? I would love to return to Lucca, but right now my family has trips lined up for Ireland and then East Germany. Can't complain.
Report Abuse
Yes mama mia, next year God willing. This year I'm going to Montepulciano, for a two week class at Il Sasso, another fantastic Italian school. Enjoy your travels!
Report Abuse
Il Sasso is on my radar for a future trip.
Oops. I should have said the FORMER East Germany, specifically Thuringia.
Report Abuse
Thanks for the report. We'll be in Lucca for 6 days in October.
Sign in to comment.


text:
Flaws reported in Trend Micro ServerProtect
Storage and security managers should be wary of vulnerabilities in the AV product that could enable a denial-of-service and malicious code execution. Workarounds are available.
This Article Covers
Attackers could exploit security holes in Trend Micro Inc.'s ServerProtect line to cause a denial-of-service or run malicious code, the iDefense division of Mountain View, Calif.-based VeriSign Inc. warned in a series of advisories.
SearchStorage writers evaluate backup's role in ransomware detection
WannaCry, NotPetya, the list of dangerous ransomware viruses goes on and on, well beyond the most highly-publicized attacks. Use this guide to learn about the extent of the threat posed by ransomware, and bolster protection of your data, apps, and systems by using the backup strategies detailed within.
By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.
You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.
ServerProtect provides comprehensive antivirus scanning for servers, detecting and removing viruses from typical and compressed files in real time before they reach the user, Trend Micro says on its Web site. The Tokyo-based vendor adds that "administrators can use a Windows-based console for centralized management of virus outbreaks, virus scanning, virus pattern file updates, notifications, and remote installation."
In addition to Trend Micro's ServerProtect product for Microsoft Windows/Novell Netware, there are also version for Linux systems, Network Appliance Inc. filters and for EMC Corp.'s Celerra file servers.
According to iDefense, the security holes are:
A denial-of-service vulnerability in the EarthAgent daemon. By exploiting this, attackers could cause the target process to consume 100% of available [central processing unit] CPU resources, iDefense said, adding, "The problem specifically exists within ServerProtect EarthAgent in the handling of maliciously crafted packets transmitted with the magic value 'x21x43x65x87' targeting TCP port 5005. A memory leak also occurs with each received exploit packet, allowing an attacker to exhaust all available memory resources with repeated attack."
Trend Micro has issued a hotfix that it says "prevents the information server's CPU usage from increasing when responding to the malicious command."
As a workaround, iDefense recommends users "employ firewalls, access control lists or other TCP/UDP restriction mechanisms to limit access to vulnerable systems on TCP port 5005."
A heap overflow flaw in the ServerProtect Management Console. Remote attackers could launch malicious code with the privileges of the underlying Web server by exploiting a problem within the relay.dll ISAPI application when large POST requests are processed with "wrapped" length values.
Another Management Console flaw allows remote attackers to do the same type of damage. "The problem specifically exists within the isaNVWRequest.dll ISAPI application upon processing of large POST requests with 'wrapped' length values," iDefense said.
The Management Console also suffers from an input validation vulnerability. Attackers could exploit this to view the contents of arbitrary files on the underlying system. "The problem specifically exists within the handling of the IMAGE parameter in the script rptserver.asp," iDefense said. "An attacker can utilize directory traversal modifiers to traverse outside the system temporary directory and access any file on the same volume."
Trend Micro said its products will eventually be updated, sealing the security holes in the process. For now, iDefense said users can mitigate the Management Console threats by employing firewalls and accessing control lists or other TCP/UDP restriction mechanisms "to limit access to the vulnerable system on the configured port, generally TCP port 80."
Dig Deeper on Data backup security
Find more PRO+ content and other member only offers, here.


text:
The Members of the BioNJ Board of Trustees are thoughtful, engaged, and committed to the work of BioNJ and we are deeply indebted for their passion for Patients and for inspiring our work each day.
Board Officers
Chairman: James Sapirstein, R.Ph., MBA
ContraVir Pharmaceuticals, Inc., Chief Executive Officer
James Sapirstein, R.Ph., brings over thirty years of pharmaceutical industry experience to ContraVir Pharmaceuticals, Inc. (CTRV:NASDAQ). After beginning his career in 1984 with Eli Lilly, he accepted a position at Hoffmann-LaRoche in 1987, where he served for almost a decade as part of its sales and marketing teams. He held a number of positions at Hoffmann-LaRoche, including Product Director and International Operations Manager, and was actively involved with numerous product launches including several antivirals. In 1996, he became the Director of International Marketing of the Infectious Disease Division at Bristol Myers Squibb (BMS). Mr. Sapirstein directed the international HIV product marketing strategy at BMS and was an integral part of the international development and launch of a number of infectious disease products while at BMS.
James then decided to move into the Biotech arena at Gilead Sciences, Inc. (GILD). He served in the Global Marketing group at Gilead, beginning in 2000 where he led and developed the global marketing strategy for its flagship HIV drug, Viread. He played a key role in the development of the drug combination strategy that resulted in Gilead's acquisition of Triangle's nucleoside portfolio. That acquisition ultimately led to the launch of Truvada, Gilead's multi-billion dollar combination HIV drug. In 2002, he accepted the position of Executive Vice President for Serono Laboratories where he led a team of over 100 professionals to rebuild a struggling HIV and pediatric growth hormone business. As the founding CEO of Tobira Therapeutics, a New Jersey based biopharmaceutical company focused on the development of novel HIV and infectious disease compounds, he was instrumental in helping to raise over $60 million in venture capital and research funding to enable Tobira to further its scientific development. As a result of those efforts, he was named one of New Jersey's top 50 most influential people in healthcare in 2010 by NJBiz.com. Tobira was acquired earlier this year by another New Jersey based company, Allergan. Just prior to joining Contravir, James was CEO of Alliqua Therapeutics at Alliqua, Inc., where he helped lead the transformation of transdermal wound care and drug delivery technology into a premier wound care organization. Mr. Sapirstein developed the growth strategies for the organization and was responsible for several key licensing opportunities which lead to an increased return on investment for all of the shareholders.
Immediate Past Chair: Stuart W. Peltz, Ph.D.
PTC Therapeutics, Inc., Chief Executive Officer
Stuart W. Peltz, Ph.D. is a co-founder of PTC and has served as Chief Executive Officer and a member of the board of directors since the company's inception in 1998. Prior to founding PTC, Dr. Peltz was a Professor in the Department of Molecular Genetics & Microbiology at the Robert Wood Johnson Medical School, Rutgers University. Dr. Peltz has published over 80 publications in the area of post-transcriptional control processes and has received a number of scientific awards, including being elected as a Fellow of the American Academy for the Advancement of Science. Dr. Peltz received a Ph.D. from the McArdle Laboratory for Cancer Research at the University of Wisconsin. He was the 2014 recipient of the BioNJ Dr. Sol J. Barer Award for Vision, Innovation and Leadership.
President and CEO: Debbie Hart, MS, CAE, APR
BioNJ, President and CEO
Debbie Hart, founding President and CEO of BioNJ, is dedicated to the mission and work of BioNJ. She worked alongside New Jersey's biotechnology industry leaders to establish BioNJ in 1994 and has been dedicated to the organization since then. Debbie has been active on the boards and committees of numerous government and academic institutions.
Debbie was recently named by Governor Christie to the New Jersey Commission on Higher Education and Business Partnerships and appointed to the New Jersey Biotechnology Task Force. She is also a founding board member and officer of OpportunityNJ, a non-profit organization working toward a strong and sustainable State economy; is on the board of the New Jersey Chamber of Commerce and is a member of the Board of Directors for Choose New Jersey.
She was appointed by Governor Chris Christie and Lt. Governor Kim Guadagno to the NJ Council on Innovation. She was recently named to the Advisory Boards of the New Jersey Innovation Institute and the Institute for Life Sciences Entrepreneurship at Kean University. She is a member of the New Jersey Economic Development Authority's (EDA) Technology Advisory Board and a former member and Chair of EDA's Commercialization Center for Innovative Technologies (CCIT). Debbie served on the transition teams of two former New Jersey governors and was appointed by two Governors to the New Jersey Israel Commission for her work in economic development.
Past government support activities include the Prosperity New Jersey Pharmaceutical and Biotechnology Cluster Study commissioned by a former Governor and conducted by Professor Michael Porter of the Harvard Business School, the Jobs Growth and Economic Development Commission established by a former Governor and chaired by Dr. Roy Vagelos as well as the Task Force on Higher Education Quality and Competitiveness of the State. She also served on the Business Task Force established by the New Jersey State Legislature in 2011.
A strong advocate for advancing education, Debbie serves as a board member of the Rutgers University Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management at Rutgers University Business School, and has served on the Advisory Board of the College of Science and Mathematics at Montclair University, the Rothman Institute of Entrepreneurship at Fairleigh Dickinson University's Silberman College of Business and the Science Advisory Board at Rider University as well as the advisory boards for the New Jersey Institute of Technology's (NJIT) Biomedical Engineering Program, Monmouth University's School of Science, Technology and Engineering and as a Director of the Liberty Science Center's Women's Leadership Council.
Debbie served on the advisory board that guided the establishment of the nationally recognized Monmouth County Biotechnology High School and as a member of the New Jersey Healthcare Businesswomen's Association (HBA) Advisory Board. In 2005, she delivered the Commencement Address at Raritan Valley Community College's graduation ceremonies.
As an advocate for the industry, Debbie has testified before State and federal legislative committees. She is also a frequent speaker at industry events, including serving as the Keynote speaker at the Russian Pharmaceutical Forum in St. Petersburg, Russia; the Knowledge for Growth Conference in Ghent, Belgium; the Women's Clinical Leadership Forum at the Partnerships in Clinical Trials conference in Orlando, Florida; and the Shanghai Bio Conference in Shanghai.
Debbie was honored by the Women's Fund of New Jersey as a Woman Advancing Science, and she and BioNJ were recognized by NJIT with a New Jersey Inventors Hall of Fame Award.
Debbie is an NJBIZ New Jersey's Best 50 Women in Business honoree. In March 2014 in commemoration of Women's History Month, she was nominated by Assemblywoman Pamela Lampitt and honored by the New Jersey General Assembly as a Woman Advancing Science. In May 2014, Debbie was named as one of 50 people to PolitickerNJ's Health Care Power List of 2014.
Most recently, Debbie was named one of the world's 100 Most Influential People in Biotechnology by Scientific American Worldview; as one of HudsonMod Magazine's 2015 list of Women in Power along with Diane Von Furstenberg, Ivanka Trump, Sandra E. Peterson, Sheri McCoy and Nina Mitchell Wells; one of New Jersey's top CEOs by COMMERCE Magazine; one of New Jersey's 2015 Top 25 Leading Women Entrepreneurs & Business Owners by Leading Women Entrepreneurs and for the fifth time in 2017 to the NJBIZ Power 100, a listing of the 100 most influential people in New Jersey business.
Debbie holds an M.S. from the S. I. Newhouse School at Syracuse University where she graduated cum laude and a B.A. from Trenton State College, now The College of New Jersey, where she graduated magna cum laude.
Vice Chairman: Daniel J. O'Connor, J.D.
Mr. O'Connor was appointed Advaxis' President and Chief Executive Officer in August 2013 at a time when the company was a "penny stock," had no cash and was burdened with significant debt. Undeterred, he executed a turnaround strategy rooted in an understanding of the potential of Advaxis' Lm Technology™ platform. From leading Advaxis' uplisting to Nasdaq, to assembling the company's executive team, to securing high-profile collaboration agreements with Merck and MedImmune and overseeing the initiation of clinical trials in HPV-associated cancers, HER2 expressing tumors and prostate cancer, Mr. O'Connor has successfully transformed Advaxis financially, clinically and operationally, providing a strong balance sheet that has enabled the company to advance one of the most diverse and active immunotherapy pipelines in the industry.
Secretary: Christian Kopfli, Esq.
Chromocell Corporation, Chief Executive Officer
Christian co-founded Chromocell in 2002, serving initially as General Counsel before becoming Chief Executive Officer in 2005.
Prior to joining Chromocell, he was an Associate at Davis Polk & Wardwell, working in its New York City, Tokyo and Frankfurt offices.
At Davis Polk, Christian worked extensively in Mergers & Acquisitions, Capital Markets and Private Equity Transactions.
He received a doctoral degree in law (magna cum laude) from the University of Zurich in 2000 and earned his LL.M. from Columbia Law School in New York City in 1998. Christian is a Board Member of BioNJ and admitted to the Bar in New York and Switzerland.
Treasurer: Scott White
President, Janssen Immunology, Janssen Biotech, Inc.
Mr. White is a seasoned business leader with more than 25 years at Johnson & Johnson in positions of increasing seniority in the commercial and research & development organizations. In his current role as President, Janssen Immunology, he sets strategic direction and drives business opportunities for the Immunology franchise in the U.S., home to some of the largest brands in the Pharmaceutical industry including REMICADE®, STELARA®, SIMPONI® and SIMPONI ARIA®. Mr. White serves as a member of the Janssen Americas Leadership Team and on the BioNJ board of directors as the representative for Janssen.
Most recently, Mr. White was President of Janssen Oncology where he was responsible for commercialization of the Janssen U.S. oncology portfolio during a period of unprecedented growth. With the launch of two transformational oncology brands – IMBRUVICA® for chronic lymphocytic leukemia and DARZALEX® for multiple myeloma, Janssen Oncology is now one of the fastest growing Oncology companies.
Previously, Mr. White held the position of Vice President, Strategic Customer Group serving all Janssen U.S. businesses. In this role, he was the market access leader on the Janssen North America Pharmaceuticals Leadership Team and led the organization's transition to working within a new healthcare environment under the Affordable Care Act. Mr. White has also served as Vice President of Marketing for Janssen Immunology where he was responsible for growing its immunology portfolio. He began his career at Johnson & Johnson in drug discovery and clinical development.
Mr. White holds a Bachelor of Arts from Rutgers, The State University of New Jersey, where he double-majored in molecular biology and philosophy. He also received a Master of Business Administration from the University of Phoenix.
Board Members
Sol J. Barer, Ph.D.
Former Chairman, Celgene Corporation
Chairman of the Board, Edge Therapeutics, Inc. and Teva Pharmaceuticals
Dr. Barer spent most of his professional career with the Celgene Corporation. He was Chairman from January 2011 until June 2011, Executive Chairman from June 2010 until Jan 2011 and Chairman and Chief Executive Officer from May 2006 until June 2010. Previously he was appointed President in 1993 and Chief Operating Officer in 1994 before assuming the CEO position. He also served as Senior Vice President, Science and Technology, and Vice President/General Manager, Chiral Products, from October 1990 to October 1993, and Vice President, Technology, from September 1987 to October 1990. Dr. Barer was the founder of the biotechnology group at the Celanese Research Company which was subsequently spun out to form Celgene.
Dr. Barer serves as Chairman of the Board of the public companies Edge Therapeutics, InspireMD and Medgenics and private company Centrexion, is Lead Director of ContraFect and is on the Board of Directors of the public companies Amicus Therapeutics and Teva Pharmaceutical Industries. He is a Venture Advisor to the Israel Biotechnology Fund as well as an advisor to biopharma companies.
In 2011 Dr. Barer was Chairman of the University of Medicine and Dentistry of New Jersey Governor's Advisory Committee which resulted in sweeping changes in the structure of New Jersey's medical schools and public research universities. He previously served as a Commissioner of the NJ Commission on Science and Technology. He was a member of the Board of Trustees of Rutgers University (until 2013). He also served two terms as Chair of the Board of Trustees of BioNJ (2010-2012) the New Jersey biotechnology organization.
Dr. Barer was named to the "Worldview 100" (Scientific American's 100 most influential figures in today's world of biotechnology) in 2015, named one of "25 Leadership Legends of NJ" (NJBiz) in 2012, "The 50 Most Powerful People in N.J. Health Care," in 2012, inducted into the NJBiz Hall of Fame in 2011 and was named as one of NJ's top 10 scientists by New Jersey Business in 2008. Dr. Barer has received countless professional awards and honors.
Ambaw Bellete
Photocure, Inc., President
Ambaw Bellete is the President of Photocure Inc a position that he has held since January 2012. He has nearly 27 years of experience in the biopharmaceutical and medical device industry. He has most recently ran two startup companies from inception to commercialization. Mr. Bellete has held senior executive positions across multiple therapeutic areas in business development, commercial operations, managed care, marketing and sales at companies such as Pharmacia and Sanofi. Prior to joining Photocure, he was most recently President of Medical Compression Systems. He has been a Trustee of BioNJ since April 29, 2015.
Bradley L. Campbell
Amicus Therapeutics, President and Chief Operating Officer
Bradley L. Campbell brings over 15 years of experience in the Orphan Drug industry. He serves as President and Chief Operating Officer of Amicus Therapeutics (NASDAQ: FOLD), a biotechnology company based in Cranbury, New Jersey, focused on developing next‐generation medicines to treat a range of rare and orphan diseases. In his current capacity, Mr. Campbell leads the strategy, design and execution of global commercial operations to support the launch of GalafoldTM, a small molecule personalized medicine approach in development for the treatment of Fabry Disease. In addition, he oversees the Business Development, Patient Advocacy and Program Management functions. Bradley joined Amicus in 2006 as Sr. Director of Business Development and subsequently took on various roles of increasing responsibility including leadership of the Commercial Planning, Technical Operations and Science organizations among others.
Prior to joining Amicus, Mr. Campbell was with Genzyme, serving first as Sr. Product Manager for Myozyme®, Genzyme's ERT for Pompe disease, and later as Business Director of their cardiac gene therapy programs, responsible for business development and commercial planning. He has also worked in sales & marketing and strategy & operations for Bristol-Myers Squibb, and as a strategy consultant for Marakon Associates.
Mr. Campbell has been active in various philanthropic organizations. He is a past President of the National Tay-Sachs and Allied Diseases Association Board of Directors, and he currently sits on their Corporate Advisory Council. Bradley received a B.A. in Public Policy from Duke University and an M.B.A. from Harvard Business School.
Meeta Chatterjee, Ph.D.
Head, Business Strategy and Operations, Business Development and Licensing, Merck Research Laboratories
Dr. Chatterjee has 30 years of broad strategic and operational experience in pharmaceutical research & development, in-licensing and externalization activities. In her current role, she is responsible for overseeing business strategy and operations, including departmental structure, governance, oversight and control within the research laboratories and across divisions. Additionally, she continues her role overseeing Merck's Out-licensing efforts from her former position.
Previously, Dr. Chatterjee headed Merck's Global Out-licensing and Asset Management team responsible for out-licensing activities. In this role, she expanded Merck's business model to include the externalization of development compounds/programs, technologies, devices, and formulations to targeted partner organizations. Dr. Chatterjee started her career in the Cardiovascular Discovery Research group at Schering Plough. As head of the Vascular Biology group, she led research efforts in the areas of hypertension, atherosclerosis and obesity. These efforts ultimately led to the discovery and development of Zetia® and Zontivity®. She later served as Executive Director, R&D Licensing at Schering Plough Research Institute.
Dr. Chatterjee received her undergraduate education at St. Xavier's University in Ahmedabad, India and Rutgers University (B.A., Hons Physics). She received a Ph.D. in Physiology from Rutgers University and completed a postdoctoral fellowship in the Department of Physiology at The University of Virginia School of Medicine. Meeta is active in several industry and licensing focused organizations including BIO and the Licensing Executives Society.
Paul G. Howes
ThromboGenics, Inc., Executive Chairman
Mr. Howes currently serves as Executive Chairman of ThromboGenics, Inc., the US operating subsidiary of Belgian biotech company ThromboGenics, NV. He also serves as a Director on the parent company's Board. Prior to ThromboGenics, Mr. Howes was the President & CEO of Inotek Pharmaceuticals, a NASDAQ-listed junior biotech company active in ophthalmic drug development. Mr. Howes has over 25 years of commercial strategy, product development and sales and marketing experience in pharmaceuticals and medical devices.
Prior to joining Inotek, Mr. Howes was President of the Americas Region for Bausch & Lomb with leadership responsibility for the United States, Canada, Latin America and South America across Bausch & Lomb's Vision Care, Surgical and Pharmaceuticals business segments. Prior to joining Bausch & Lomb in 2003, Mr. Howes spent the previous 16 years in various senior management roles at Merck & Co. Inc. This experience included roles as Executive Director of Hospital Marketing, Vice President of Sales and Marketing for Specialty Products, President & CEO of the DuPont Merck Pharmaceutical Company and President of Merck Frosst Canada, Inc. Prior to Merck, Mr. Howes spent 11 years at Price Waterhouse Canada.
Mr. Howes is a graduate of Harvard College and earned his MBA from York University in Toronto, Canada. He is a member of the Canadian Institute of Chartered Professional Accountants, and currently serves as Chairman of the Board for Prevent Blindness.
Michele Korfin
Vice President, Market Access, Kite Pharma, Inc.
Ms. Korfin joined Kite in April, 2016. Her responsibilities at Kite include overseeing Payer Relations, Government Affairs, and Kite KonnectTM. Kite KonnectTM is being developed to assure a positive personalized experience for health care providers and the patients who may receive a Kite CAR-T therapy.
Prior to joining Kite, Ms. Korfin spent over 11 years at Celgene in a number of different roles spanning Commercial and Project Leadership. These roles included the Global Project Leader for Lenalidomide in Lymphoma, Head of U.S. Market Access, Oncology Team National Sales Director and leadership roles in U.S. and Global Marketing. While at Celgene, she led the creation of the nationally recognized Celgene Patient Support program. Celgene Patient Support was developed to be a dedicated team to assist patients and health care providers with access to Celgene Hematology/Oncology drugs. She also was integral for the successful launches of REVLIMID® for MDS and Multiple Myeloma, THALOMID® for Multiple Myeloma, ISTODAX® for CTCL and PTCL, and ABRAXANE® for NSCLC and Pancreatic Cancer.
Ms. Korfin also worked at Schering-Plough in Commercial roles, at Bain Consulting in Boston, and at Merck in the Manufacturing Division. She has a B.S. in Pharmacy from Rutgers University and an MBA from Harvard University. Michele is a licensed pharmacist in New Jersey.
John Maki
Vicus Therapeutics, President and Chief Executive Officer
John Maki previously served as Managing Director of Technology Directors, Inc., as Managing Director of Audax Group and as Principal, Bain Capital, as well as consultant, Bain & Company.
Mr. Maki holds an AB degree from Harvard University. Mr. Maki has over 25 years of industry experience and has been founding investor and/or board member of eleven life science companies. In addition, four of Mr. Maki's portfolio companies had successful IPOs and grew to a combined market capitalization exceeding $2.5 billion dollars. Mr. Maki currently serves on the boards of 3DMatrix, a wound healing device company and Vicus Therapeutics. Mr. Maki also serves on the Board of Trustees of BioNJ.
Anthony Marucci, MBA
Celldex Therapeutics, Inc., Founder, President, Chief Executive Officer and Director
Mr. Marucci is a Founder of Celldex and serves as the Company's President and Chief Executive Officer and as a member of the Board of Directors. Prior to his appointment as President and CEO in 2008, Mr. Marucci served as Vice President, Chief Financial Officer, Treasurer and Secretary of Celldex. Celldex, founded in 2004 as a subsidiary of Medarex (Medarex is now a wholly-owned subsidiary of Bristol Myers Squibb), was initially spun out as an independent private company in October 2005 with the asset acquisition of CDX-110 from Alteris Therapeutics, Inc. and the acquisition of Lorantis Limited (Cambridge, UK). In addition to these acquisitions, Mr. Marucci is also responsible for the AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. merger completed during the first quarter of 2008 and the acquisition of CuraGen Corporation completed in the third quarter of 2009. He was Treasurer of Medarex from December 1998 to March 2004, where he held a series of senior financial positions since December 1998. He is a member of the Board of Trustees of BioNJ and also served as its Treasurer through 2010. Mr. Marucci received a B.S. in Accounting from Kean University, an MBA from Columbia University and an MHL from Brown University
Matthew Roden, Ph.D.
Vice President and Head of Strategic Corporate Development, Bristol-Myers Squibb Company
Matthew Roden is Vice President and Head of Strategic Corporate Development at Bristol-Myers Squibb. In this role, Dr. Roden works in close collaboration with leaders across the organization to recommend creative options and proactive strategies to expand the R&D and product portfolio. Dr. Roden also oversees the Mergers & Acquisition (M&A) team responsible for acquisitions, structured transactions and divestitures. Prior to joining BMS, he was a Senior Equity Analyst and Head of the Biotechnology Equity Research Team at UBS, leading coverage of large, mid- and small-cap biotechnology stocks. In this role, Dr. Roden strove to be a Street leader in clinical trial analysis, commercial ramp projections and the regulatory and payer landscape. Earlier, Dr. Roden was a Vice President and Senior Biotech Analyst at Bank of America Merrill Lynch and J.P. Morgan, the latter of which helped drive the Institutional Investor #2-ranked large cap biotech franchise. His equity research career started in 2005 at Credit Suisse First Boston as an Associate Analyst covering biotechnology. Dr. Roden holds a Ph.D. in Microbiology and Immunology from the Albert Einstein College of Medicine, and prior was a pre-IRTA Fellow in immuno-oncology at the National Cancer Institute. He also holds a M.S. degree from Georgetown University and a B.S. degree from George Mason University.
Spiro Rombotis
Cyclacel Pharmaceuticals, Inc., President & Chief Executive Officer
Mr. Rombotis joined Cyclacel as its first CEO in 1997 and has 30 years of experience with biopharmaceutical companies. He was previously Vice President, International Operations and Business Development; Managing Director, Europe; and Representative Director, Japanese joint venture, at The Liposome Company, subsequently acquired by Elan. He held various executive roles at Bristol-Myers Squibb Company, most recently as Vice President, Pharmaceuticals Central and Eastern Europe. He was Head of European Marketing and Sales, Head of Corporate Development and one of the first employees of Centocor, subsequently acquired by Johnson & Johnson, and worked in Business Development at Novartis AG.
He holds a BA from Williams College and an MBA and Master's degree in Hospital Management with honors, from the Kellogg Graduate School of Management, where he serves on the Kellogg Biotech Advisory Board. He also serves on the Board of Trustees of BioNJ.
Alan L. Rubino
Emisphere Technologies, Inc., President & Chief Executive Officer
Alan L. Rubino joined Emisphere in 2012 as President and Chief Executive Officer. Upon joining, he was also appointed as Class II Director of the Company. Mr. Rubino's career spans over 30 years at every level of the biopharmaceutical industry.
Previously, he was President and CEO of New American Therapeutics Inc., a private specialty pharmaceutical company that acquired, marketed and developed therapeutic products and achieved major success through the acquisition, marketing, and eventual sale of its herpes labialis drug, Denavir® where the team tripled sales in 18 months and sold the asset for a multiple of three times sales. Mr. Rubino served before New American Therapeutics, Inc. as the CEO and President of Akrimax Pharmaceuticals, where he and team acquired Tirosint® and NitroMist®, two key NDA approved launch products. Rounding out his background, he had also been President and COO of another publicly-held entity, Pharmos Corporation, where he led the transformation of the company through the acquisition of Vela Pharmaceuticals. Mr. Rubino also spent four years in senior leadership positions on the strategic services side of the healthcare sector with two other public companies, Cardinal Health and PDI Inc.
A major portion of Mr. Rubino's highly successful career includes his 24 years at Hoffmann-La Roche, now Genentech (a subsidiary of Roche) which remains one of the world's top 10 biopharmaceutical companies. At Roche, he was a corporate officer and member of the U.S. Executive Committee. He held a variety of key senior executive positions that encompassed business operations, business strategy, human resources, marketing, sales, corporate development and strategic planning.
Mr. Rubino currently serves on the Corporate Boards of Aastrom Biosciences, Genisphere, Inc. and Sanuwave Health, Inc. For the past 17 years, he has served on the Board of Rutgers University School of Business and the Lerner Center for Pharmaceutical Studies. Mr. Rubino holds a B.A. in economics from Rutgers University along with a full minor in biology and chemistry.
Christopher J. Schaber, Ph.D.
Soligenix, Inc., President and Chief Executive Officer
Christopher J. Schaber, Ph.D. has over 27 years of experience in the pharmaceutical and biotechnology industry. Dr. Schaber has been Soligenix's President and Chief Executive Officer and a director since August 2006. In addition to serving as Chairman of the Board of Directors for Soligenix, he also serves on the boards of the Alliance for BioSecurity and f BioNJ. He is a member of the corporate councils for both the National Organization for Rare Diseases (NORD) and the American Society for Blood and Marrow Transplantation (ASBMT).
Prior to joining the company, Dr. Schaber served from 1998 to 2006 as Executive Vice President and Chief Operating Officer of Discovery Laboratories, Inc., where he was responsible for overall pipeline development and key areas of commercial operations, including regulatory affairs, quality control and assurance, manufacturing and distribution, preclinical and clinical research, and medical affairs, as well as coordination of commercial launch preparation activities. From 1996 to 1998, he was a co-founder of Acute Therapeutics, Inc., and served as its Vice President of Regulatory Compliance and Drug Development. From 1994 to 1996, he was employed by Ohmeda PPD, Inc., as Worldwide Director of Regulatory Affairs and Operations. From 1989 to 1994, Dr. Schaber held a variety of regulatory, development and operations positions with The Liposome Company, Inc., and Elkins-Sinn Inc., a division of Wyeth-Ayerst Laboratories.
Dr. Schaber received his BA from Western Maryland College, his MS in Pharmaceutics from Temple University School of Pharmacy and his Ph.D. in Pharmaceutical Sciences from the Union Graduate School. During his career, Dr. Schaber has played a significant role in raising in excess of $200 million through both public offerings and private placements.
Marco Taglietti, M.D.
SCYNEXIS, Inc., President and Chief Executive Officer
Dr. Taglietti joined Scynexis' Board of Directors in 2014 as an independent Director becoming Scynexis' CEO and President in April 2015. He served as Executive Vice President, Research and Development and Chief Medical Officer of Forest Laboratories, Inc. and also as President of the Forest Research Institute until its purchase by Actavis in 2014. During his career at Forest, Stiefel and Schering-Plough, Dr. Taglietti has brought to market more than 35 different products in the U.S. and internationally through a variety of regulatory strategies including NDA 505(b)1 and 505(b)2, 510k medical device, ANDA for generics and EMA MAA in many different therapeutic areas, including anti-infectives, oncology, psychiatry, neurology, cardiovascular, respiratory, dermatology, metabolism and internal medicine.
Monika A. Vnuk, M.D.
Business Development Group Lead, Pfizer Vaccines, Pfizer, Inc.
Dr. Monika A. Vnuk leads business development activities for Pfizer Vaccines. Since joining Pfizer in 2008, Dr. Vnuk has been responsible for leading the evaluation, execution and negotiations of many business transactions, including licensing deals, collaborations, joint-ventures and mergers and acquisitions.
Before joining Pfizer, Dr. Vnuk was a vice president at Banc of America securities. During her time with Banc of America, Dr. Vnuk worked with life sciences companies helping clients complete initial public offerings, private placements and strategic transactions. Prior to her position at Banc of America, she was a Principal at Oxford Bioscience Partners, a venture capital firm focused on early stage biotechnology investments. During her five years with Oxford, Dr. Vnuk worked with the investment team in forming several biotechnology and medical device start-ups and helping portfolio companies complete private financing transactions. Prior to that job, Dr. Vnuk was a Fellow at the Health Care Entrepreneurship Program at Boston University.
Dr. Vnuk is a 2000 Inductee to the Alpha Omega Alpha Medical Honor Society. Dr. Vnuk holds a B.A. in Mathematics and Philosophy from Boston University and an M.D. from Boston University School of Medicine.
Ji Zhang, Ph.D.
Senior Vice President, Head of R&D Operations, Sanofi
As head of R&D Operations, Dr. Zhang's teams integrate interdisciplinary scientific and clinical operations across the scientific platforms in preclinical, CMC development and clinical development areas, to provide expertise and high caliber support to R&D projects, delivering new medicines with high quality, reduced cycle time and well controlled cost. He has overall responsibility for operational strategy, infrastructure and capital investment, and productivity improvements in R&D operations. Prior to joining Sanofi in 2003, Dr. Zhang worked at Merck Research Laboratories. Dr. Zhang has been extensively published in clinical development research areas. He holds a B.S. and M.S. in mathematics, probability and statistics from Peking University, China and earned a Ph.D. in statistics from North Carolina State University.


text:
While installing Canon's MX700 all-in-one printer on Windows, I spotted this for my collection of bad dialogs:
Hint: if you ask the user a question, it's good to allow for more than one answer. Even if you close the dialog by clicking the x at top right, it still reboots the system.
I was also interested to see whether the printer works with Linux. Canon doesn't offer Linux drivers. Nor does it seem keen to hear from customers about this:
The CAPTCHA test always presents 8 zeroes, which it then rejects as invalid.
I haven't quite given up. There are Linux drivers for the Pixma MP520 which are rumoured to work somewhat. When I have a moment I'll give it a try.
Related posts:
- What next for Embarcadero Delphi? Roadmap with Mac, Linux support published.
- Microsoft reports weak financials, still failing in the cloud
- HTML5 scorecard: Amazon Kindle Fire weak, iOS 5 great, IE10 preview one of the best
- CodeGear (Borland) to support PHP tools
- Will Adobe's tools ever run on Linux?


text:
Forgot your password? Enter the email address you signed up with and we will send you a link to create a new password.
Your password reset has been submitted to the address provided.
Design plus words, letters, and/or numbers
processed tree nuts, peanuts, fruits, sunflower seeds, sunflower kernels, raisins or combinations thereof that are bagged or boxed and/or candied
Business in Madison Heights, MI


text:
Research Topics
Douglas Conrad
Affiliation: University of Washington
Country: USA
Detail Information
- Design, rationale, and baseline characteristics of a cluster randomized controlled trial of pay for performance for hypertension treatment: study protocolLaura A Petersen
Health Policy and Quality Program, Michael E, DeBakey VA Medical Center Health Services Research and Development Center of Excellence, and Section for Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Implement Sci 6:114. 2011..Despite compelling evidence of the benefits of treatment and well-accepted guidelines for treatment, hypertension is controlled in less than one-half of United States citizens...
- Primary care physician compensation method in medical groups: does it influence the use and cost of health services for enrollees in managed care organizations?D A Conrad
Department of Health Services, University of Washington, Seattle 98195 7660, USA
JAMA 279:853-8. 1998..Growth of at-risk managed care contracts between health plans and medical groups has been well documented, but less is known about the nature of financial incentives within those medical groups or their effects on health care utilization...
- Estimating determinants of dentist productivity: new evidenceDouglas A Conrad
Center for Health Management Research, University of Washington, Box 357660, Room H660C, 1959 NE Pacific Street, Health Sciences Center, Seattle, WA 98195 7660, USA
J Public Health Dent 70:262-8. 2010..Productivity (output per unit of input) is a major driver of dental service capacity. This study uses 2006-2007 data to update available knowledge on dentist productivity...
- Lessons to apply to national comprehensive healthcare reformDouglas A Conrad
Department of Health Services, University of Washington, 1959 NE Pacific St, Box 357660, Room H660C Magnuson Health Sciences Ctr, Seattle, WA 98195 7660, USA
Am J Manag Care 15:S306-21. 2009..If widely implemented, value-based reforms might achieve long-term improvements in public health. Congress will soon decide whether changing the entire system would be the most value-based reform of all...
- Determinants of general dentists' decisions to accept capitation payment: a conceptual model and empirical estimatesDouglas Conrad
Department of Health Services, University of Washington, Seattle, WA 98195 7660, USA
Community Dent Oral Epidemiol 37:189-98. 2009....
- Quality-based financial incentives in health care: can we improve quality by paying for it?Douglas A Conrad
Department of Health Services, University of Washington, Seattle, Washington 98195, USA
Annu Rev Public Health 30:357-71. 2009..g., prevention) most amenable to piece-rate delivery...
- Access intervention in an integrated, prepaid group practice: effects on primary care physician productivityDouglas Conrad
Department of Health Services, University of Washington, Box 357660, Suite H660C, Seattle, WA 98195 7660, USA
Health Serv Res 43:1888-905. 2008..To estimate the joint effect of a multifaceted access intervention on primary care physician (PCP) productivity in a large, integrated prepaid group practice...
- Memories of Walter J. McNerney: his contributions to health administration and to health administration educationDouglas A Conrad
Center for Health Management Research, University of Washington, Box 357660, Room H 660, Magnuson Health Sciences Center, 1959 NE Pacific Street, Seattle, WA 98195 7660, USA
J Health Adm Educ 23:331-4. 2006
- Paying physicians for quality: evidence and themes from the fieldDouglas A Conrad
Jt Comm J Qual Patient Saf 32:443-51. 2006....
- Paying physicians for quality: evidence and themes from the fieldDouglas A Conrad
Department of Health Services, Magnuson Health Sciences Center, University of Washington, Seattle, USA
Jt Comm J Qual Patient Saf 32:443-51. 2006..Key-informant interviews with leaders of provider organizations should shed new light on evolving quality incentives within organizations...
- Effect of compensation method on the behavior of primary care physicians in managed care organizations: evidence from interviews with physicians and medical leaders in Washington StateB K Zierler
University of Washington, Seattle 98195 6410, USA
Am J Manag Care 4:209-20. 1998..The responses revealed in interviews with physicians and administrative leaders underscored the critical role compensation arrangements play in driving physician satisfaction and behavior...
- Physician practice management organizations: their prospects and performanceD A Conrad
University of Washington, USA
Med Care Res Rev 56:307-39. 1999....
- Providing dental care to pregnant patients: a survey of Oregon general dentistsColleen E Huebner
Department of Health Services, University of Washington, Seattle, WA 98195 7230, USA
J Am Dent Assoc 140:211-22. 2009..A growing number of studies and reports indicate preventive, routine and emergency dental procedures can be provided safely to pregnant patients to alleviate dental problems and promote oral health of mothers and children...
- A report on eight early-stage state and regional projects testing value-based paymentDouglas Conrad
Center for Health Management Research, University of Washington, Seattle, WA, USA
Health Aff (Millwood) 32:998-1006. 2013..We also share some early lessons and identify prerequisites for success, such as ensuring that providers have broad and timely access to data so they can meet patients' needs in cost-effective ways...
- Penetrating the "black box": financial incentives for enhancing the quality of physician servicesDouglas A Conrad
University of Washington, USA
Med Care Res Rev 61:37S-68S. 2004..The model is extended qualitatively to offer further hypotheses and research directions. Finally, gaps and limitations of the model and of the extant empirical research are articulated, and additional researchable questions are posed...
- Does payment drive procedures? Payment for specialty services and procedure rate variations in 3 HMOsBarry G Saver
Department of Family Medicine, University of Washington, Seattle, Wash 98195 4696, USA
Am J Manag Care 10:229-37. 2004..To study how payment for specialty services affects the rates of performance of invasive procedures by physicians in a number of specialties...
- Evaluation of the group health cooperative access initiative: study design challenges in estimating the impact of a large-scale organizational transformationDavid Grembowski
Group Health Cooperative, Center for Health Studies, Washington, Seattle, USA
Qual Manag Health Care 17:292-303. 2008..The methods may be generalizable to evaluating similar reforms in other integrated delivery systems with representative patient and physician data sources...
- Group health cooperative's transformation toward patient-centered accessJames D Ralston
Center for Health Studies, Seattle, Washington, USA
Med Care Res Rev 66:703-24. 2009....
- Are local health department expenditures related to racial disparities in mortality?David Grembowski
University of Washington, Seattle, WA 98195 7660, USA
Soc Sci Med 71:2057-65. 2010....
- The impact of financial incentives on physician productivity in medical groupsDouglas A Conrad
University of Washington, Department of Health Services, Seattle 98195 7660, USA
Health Serv Res 37:885-906. 2002..To estimate the effect of financial incentives in medical groups--both at the level of individual physician and collectively--on individual physician productivity...
- Medicaid reforms in Oregon and suboptimal utilization of dental care by women of childbearing agePeter Milgrom
Northwest Center to Reduce Oral Health Disparities, Department of Dental Public Health Sciences, University of Washington, Box 357475, 1959 Pacific St, Seattle, WA 98195 7475, USA
J Am Dent Assoc 141:688-95. 2010..They also compared differences in claims between those for women enrolled in managed care and those for women enrolled in fee-for-service plans...
- Dentists' perceptions of barriers to providing dental care to pregnant womenRosanna Shuk Yin Lee
Department of Dental Public Health Sciences, University of Washington, Seattle, Washington 98195 7475, USA
Womens Health Issues 20:359-65. 2010....
- Evaluating partnerships for community health improvement: tracking the footprintsStephen M Shortell
School of Public Health, University of California, Berkeley, USA
J Health Polit Policy Law 27:49-91. 2002..We explore the implications of this research for future evaluations of public-private community health partnerships...
- Practical issues in the design and implementation of pay-for-quality programsGary J Young
Department of Health Policy and Management, Boston University School of Public Health, Massachusetts, USA
J Healthc Manag 52:10-8; discussion 18-9. 2007....
- Evaluating community partnerships: a reply to Spitz and RitterStephen M Shortell
J Health Polit Policy Law 27:1023-8; author reply 1029-30. 2002


text:
More than two decades after Han Tak Lee was convicted of killing his daughter by a fire he purposely set, the Third Circuit Court of Appeals has held that the evidence against him deserves a second look.
The 76-year-old man was convicted in 1990 of killing his 20-year-old, mentally-disabled daughter, Ji Yun Lee, in a fire set at a religious retreat in the Poconos. He was sentenced to life in prison without the possibility of parole, and has been contending that he was wrongfully convicted ever since.


text:
I couldn't ignore the requests any more. I had to go and make a tutorial on "how to draw Plusle and Minun", step by step. These two adorable Pokemon are the cutest things I have seen from the Pokedex for a very long time. I can totally see these two character get really popular just because of their looks. Plulse and Minun are electric type cheering Pokemon. The two species are related even though they have different names. The red one is Plusle and as you can see it has a positive or plus sign on the cheeks and tail. The blue one is called Minun. This one has a negative or minus symbol the cheek and tail as well. They are opposites, and as you know opposites attract. Anyways drawing Plusle and Minun should be fun and exciting. I have a couple more tuts for you all so I hope you stay tuned in. Peace out amigos.
DragoArt members upload artwork and drawing tutorials! They are also allowed to leave comments on tutorials, profiles, etc. Many more features, as well; it's way better than just being a boring guest! Register Now!


text:
San Clemente , CA | Posted: A while ago
Phone Number
San Clemente , CA
Starboard Airborn 7'4″ x 28.5 Candy. Used only a couple of times some paddle blade scratches on rails, no dings. The board is in excellent condition! Retail $2000 selling for $1000 OBO
Please complete the shipping request form below and our team will respond back to you ASAP with shipping quotes from 3 of the best paddle board freight movers in the business. Keep in mind that shipping to the freight terminal / dock will be much cheaper than shipping to your home and we can work with you to find the best value for your shipping. Once you've decided on a shipping option, we will connect you with the seller of this board to make the necessary arrangements for purchase and shipping.
Your Name
Zip code top ship to
Where do you want your board shipped to?
Your HouseShipping DockOther destination
Other shipping destination
Any special shipping instructions?
Input this code :
Enter your username or email address.


text:
Artist description:
15 yr old danii realizes shes in love at the last minute. Her boyfriend decides not to see her anymore written in a letter and his chain heart choker she gave him attatched.
Java Draw Created Jul 25, 2009 470 x 338px Unless noted Copyright 2009 cheerXdrawer.
We encourage you to submit a comment and let the artist know what you think of this drawing. Please log in or join to post a comment.
Post a comment
This looks nice
if only guys wud realise this D':
expressive draw!


text:
Competition weekend for Rockport Dance
North Berwick — Friday and Saturday, March 14 and 15, nine Rockport Dance Conservatory students will travel to compete in this year's Dancers Inc Regional Dance Competition at Noble High School. The 2014 Competition Team of Moira Pieri, Sydney Fields, Sadie Mills, Piper Pavelich, Annika Charland, Kelsey Guinn, Carrie Long, Paige Chester, Elise Mahar and Cecil Tinch will present solos, duo/trios and small group numbers.
There are many dance competitions throughout the United States, and these competitions have similar formats with specific rules and special offerings. Competing production numbers are entered into a category based on dancers' age and experience range and are judged on technique, style, showmanship and precision. The numbers are critiqued in comparison to other numbers in the same age/level division.
The benefits of dance in general — strength, coordination, flexibility, discipline, commitment and teamwork — are magnified in a competition program. Rockport Dance Conservatory focuses on cultivating the balance of the benefits with some of the drawbacks, promoting dance numbers high in artistry and good technique rather than "tricks" and flash. Proper sportsmanship, group support, performance ability and creative exploration are reinforced. RDC does not require students to participate in competition.
For more information on RDC, visit rockportdance.com or find it on Facebook.
Courier Publications' A&E Editor Dagney C. Ernest can be reached at (207) 594-4401, ext. 115; or email@example.com.


text: Isaac Dupree wrote: > Natural numbers under min don't form a monoid, only naturals under max do (so > you can have a zero element) Though, FWIW, you can use Nat+1 with the extra value standing for Infinity as the identity of min (newtype Min = Maybe Nat). I bring this up mainly because it can be helpful to explain how we can take the "almost monoid" of min at Nat and monoidize it. Showing how this is similar to and different from max at Nat is enlightening. Showing the min monoid on negative naturals with 0 as the identity, and no need for the "special" +1 value, would help drive the point home. (Also, the min/max duality is mirrored in intersection/union on sets where we need to introduce either the empty set (usually trivial) or the universal set (usually overlooked).) Or maybe that would be better explained in a reference rather than the main text. -- Live well, ~wren


text:
NJHA's Holmes Named Program Director for N.J. Nursing Initiative
Jun 06, 2013, 09:59 ET from New Jersey Hospital Association (NJHA)
PRINCETON, N.J., June 6, 2013 /PRNewswire-USNewswire/ -- Aline Holmes, MSN, RN, senior vice president of clinical affairs for the New Jersey Hospital Association, has been selected by the New Jersey Nursing Initiative (NJNI) to serve as one of two program directors that will help address the state's nurse faculty shortage.
Sponsored by the Robert Wood Johnson Foundation and the New Jersey Chamber of Commerce, NJNI was launched in 2009 to address the nursing faculty shortage in New Jersey and help avert the projected shortage of more than 23,000 nurses in less than two decades.
"As a nurse and as an administrator, I've long known the fundamental role that nurses have in providing care and promoting health," Holmes said. "I'm eager to tackle the challenges in New Jersey that NJNI has focused on so tirelessly for four years."
Holmes will co-chair along with Susan W. Salmond, EdD, RN, ANEF, FAAN, who is dean and professor at the University of Medicine and Dentistry of New Jersey -School of Nursing.
Holmes also is director of the NJHA Institute for Quality and Patient Safety (www.njha.com/quality-patient-safety/) which leads statewide quality improvement efforts among hospitals and other healthcare providers. She also serves as a principal investigator/project director for several patient safety improvement initiatives funded by RWJF and the Healthcare Foundation of New Jersey, and directs NJHA's efforts under a Centers for Medicare and Medicaid Services contract to serve as a hospital engagement network in the Partnership for Patients national initiative. (www.njha.com/pfp)
A U.S. Navy Nurse Corps veteran, Holmes completed her undergraduate studies in nursing at the University of Massachusetts and received her master of science in nursing from the Catholic University of America in Washington, D.C. She is pursuing a doctorate in nursing leadership at Rutgers University. She resides in Plainsboro.
The New Jersey Hospital Association, based in Princeton, is a not-for-profit trade organization that advocates for its member hospitals and post-acute providers and the patients they serve.
SOURCE New Jersey Hospital Association (NJHA)


text:
Welcome | Sign In or Contact Us
Receive Weekly How-To Tips & Specials
Air Compressors Direct is an online
Smc Auto Drainsuperstore, specializing exclusively in Smc Auto Drain Valves, Smc Air Compressor Auto Drain Valves and Smc Air Compressor Auto Drains. Compare Smc Auto Drain Valve models, specs and prices. Consult with our experienced Smc Auto Drain experts. Smc Auto Drains for sale. Tax-Free.


text:
Use the tools below to refine your search by only displaying reviews with a certain number of star ratings or to only show reviews from a certain time period. Eg click on '1 star' to just display the reviews we have which received a 1 star rating click or 'Within the last month' to display just reviews posted over the last month.
Written on: 14/06/2014 by Carlotta1994 (1 review written)
This product has been sent back three times now. First time it smelt of burning second time filter keeps popping up despite changing it and following the blow out procedure. third time the filter keeps popping up. This problem seems to be an ongoing problem and judging by the reviews have not been addressed by Miele. When it worked it was fine for the best part of a year. Once the problems started they have not stopped. Miele said the filter was full but it was a brand spanking new filter so… Read Full Review
Written on: 28/04/2013 by martin99 (29 reviews written)
With a street price of around £200 this is quite an expensive vacuum cleaner and was well reviewed in a recent group test conducted by a reputable British consumer organisation. So my hopes for S8310 were high and they've mostly been fulfilled. It is a very light machine and very quiet with several power settings to deal with every surface you can imagine. It also excels at picking up dirt and keeps it in the bag due to the efficient filtration system. Indeed, this was my main reason for… Read Full Review
As rated by our community of reviewers
" Breaks easily " Read More
" Worst vacuum cleaner I've ever owned. " Read More
Written by Karen1960117
" Looks good but performance and reliability poor! " Read More
Written by Joff
" Waste Of Money " Read More
Written by alpacino27
" Cabbages " Read More


text:
Cold Blooded: The Clutter Family Murders
Full Series Available
Canadian duo WeWereMonkeys weren't monkeying around in this music video they directed for Land of Talk's hauntingly wistful "It's Okay." The video's contemplative concept seems to perfectly capture the song's pensive pace in a surprising and visually gorgeous style. Excuse me now while I manfully wipe my tears away and blow my nose.
WeWereMonkeys: Land of Talk – It's Okay from WeWereMonkeys on Vimeo.


text:
A D.C.-bound plane landed in Omaha after a passenger forced her way into first class screaming "terrorist" and pointing a finger at attendants aboard United Airlines Flight 142, according to the Lincoln Journal Star.
Maria Rita Manzoni reportedly pressed her call button and told a flight attendant she felt sick. On the way to the restroom, she told attendants the men sitting in her row were terrorists. She said one had a bungee cord and a voice recorder and that the other had a GPS device and a cell phone.
Manzoni was taken to the rear of the plane while the attendant questioned the men. However, the attendant wasn't convinced the men posed any threat to the aircraft, crew or passengers. Later in the flight, Manzoni "became hysterical, screaming 'terrorist' while pointing at flight attendants and pushing her way toward the cabin," said Christopher Meztista Jr., a special agent with the FBI's Omaha Division.
According to court records, a male passenger tried to intervene, but Manzoni was still able to push her way to the front of the plane, where two other male passengers and the flight attendants restrained her.
The plane was then diverted to Omaha and landed without further incident. Manzoni has been charged in U.S. District Court in Nebraska with interference with cabin and flight crew.


text:
Swanton Public Schools - starts with C
The 50States Swanton school directory. Find Swanton , Ohio school addresses, phone numbers and other school info.
Go To: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Crestwood Elementary School
Students/Teachers: 349 / 14
Grades: Pre-School - 2
101 Crestwood Dr
Swanton, OH 43558